Uncategorized

Dr. Hoen Receives R01 in 2017

Center investigator Anne Hoen has received an R01 to investigate multi-omic functional integration. This grant proposes the developing, evaluating, applying and distributing a new set of tools for performing meaningful analysis and integration of ‘omics data for human microbiota studies. This work has the potential to to help translate experimental […]

Read More

Dr. Madan Featured in 2018 Nature Article

Center Investigator Juliette Madan was featured in a Nature editorial article discussing new research suggesting the possibility of a fetal microbiome.  “There’s very little in and on the human body that could be considered sterile,” says Madan. Nature

Dr. Salas’ Research Featured on Epigenetics in 2017

Epidemiology postdoc (now assistant professor) Dr. Lucas Salas’ research was featured on the cover of the journal Epigenetics. Dr. Salas, who is in Brock Christensen’s lab, and his co-authors studied global DNA methylation dysregulation patterns across cancer types, showing a higher impact in CpG-poor areas of the genome. This work […]

Read More

Dr. Christensen Receives New R01

Center investigator Brock Christensen has received a new R01 to study biomarkers of bladder cancer. The grant proposes to leverage an existing population-based study of bladder cancer that includes a range of patient age groups, has several years of follow up, includes patient treatment and outcome data, as well as […]

Read More

Christensen Lab Distributes New Research

New research from Dr. Brock Christensen’s lab identified CpG sites that demonstrated significant associations with subject age in normal breast tissue. This study suggests that regions in the genome where DNA methylation changes occur with age are particularly sensitive to disruption in cancer. Science Daily Breast Cancer Research

Drs. Madan & Hoen Published in JAMA Pediatrics

Drs. Juliette Madan and Anne Hoen’s publication in JAMA Pediatrics (March 2016 issue) on delivery mode and the microbiome, “Association of Cesarean Delivery and Formula Supplementation with the Intestinal Microbiome of 6-Week-Old Infants” received considerable media attention. JAMA Pediatrics NPR Science Friday Interview Forbes Huffington Post

Dr. Christensen Publishes Paper in Nature Communications

Dr. Brock Christensen published a paper in Nature Communications identifying the role of two DNA modifications, 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5-hmC), in a set of 30 glioblastomas, and their relationship with patient survival. “An intense interest has emerged in detailing the functional role of distinct DNA modifications in both healthy […]

Read More